Prosecution Insights
Last updated: April 19, 2026

Bright Peak Therapeutics AG

4 pending office actions

Portfolio Summary

4
Total Pending OAs
3
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18113409 MODIFIED IL-18 POLYPEPTIDES GURLEY, JAMI MICHELLE 1647 Final Rejection Feb 23, 2023
18113399 ACTIVATABLE IL-18 POLYPEPTIDES CHATTIN, AMY MARIE 1643 Final Rejection Feb 23, 2023
17861176 ANTIBODY CONJUGATES AND MANUFACTURE THEREOF BERHANE, SELAM 1675 Non-Final OA Jul 09, 2022
17406847 MODIFIED IL-18 POLYPEPTIDES AND USES THEREOF JIANG, DONG 1674 Final Rejection Aug 19, 2021

Managing Bright Peak Therapeutics AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month